Am J Kidney Dis

1. ORTEGA-MONTIEL J, Alkabbani W, Hahn G, Liu J, et al
   Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.
   Am J Kidney Dis. 2026 Sep 21:S0272-6386(26)01118.
   

   >> Share

   
   
2. MENG X, Wang Y, Zhang X, Wang S, et al
   Time in Target Range for Hemoglobin A(1c) and Systolic Blood Pressure: Association With Adverse Kidney Events.
   Am J Kidney Dis. 2026;88:521-530.
   

   >> Share

   
   

   
   BMC Ophthalmol

3. ELMI SADR N, Ghiasian L, Hadi Y, Hariri R, et al
   The effect of cycloplegia on corneal power and diameter measured by an auto-kerato-refractometer in presbyopic patients with type 2 diabetes mellitus: a post-hoc analysis of a randomized clinical trial.
   BMC Ophthalmol. 2026;26:588.
   

   >> Share

   
   

   
   BMJ

4. TURCHIN A, Petito LC, Hegermiller E, Chelliah I, et al
   Renal outcomes in people with type 2 diabetes with and without albuminuria treated with SGLT-2 inhibitors and GLP-1 receptor agonists: target trial emulation.
   BMJ. 2026;394:e100574.
   

   >> Share

   
   
5. TANNE JH
   American Diabetes Association boycotted in free speech row.
   BMJ. 2026;394:e100925.
   

   >> Share

   
   

   
   Br J Ophthalmol

6. SPARTALIS C, Ruiss M, Dechat T, Kronschlager M, et al
   Intracapsular metformin bioactivity and its role in posterior capsule opacification.
   Br J Ophthalmol. 2026;110:1157-1163.
   

   >> Share

   
   

   
   Diabet Med

7. 
   Psychosocial care and experiences in young adults living with early-onset type 2 diabetes: A narrative review.
   Diabet Med. 2026;43:e70472.
   

   >> Share

   
   
8. WIT M, Forde R, Holmes-Truscott E
   From strength to strength: Why psychosocial research in diabetes is more important than ever.
   Diabet Med. 2026;43:e70458.
   

   >> Share

   
   
9. CLEAL B, Skovlund S, Skinner TC, O'Donnell S, et al
   Where is the social in the psychosocial? A narrative review.
   Diabet Med. 2026;43:e70201.
   

   >> Share

   
   

   
   Diabetes

10. GUO Z, Kasinathan D, Yun S, Golson ML, et al
    Islet-Targeted ZnT8 Antibodies Protect Pancreatic beta-Cells From Inflammatory Stress.
    Diabetes. 2026;75:1892-1905.
    

    >> Share

    
    
11. BURKETT JB, Fuhr J, Falk AC, Dadi P, et al
    Dual Modulation of Prostaglandin E2 Receptors EP3 and EP4 Protects beta-Cell Mass in a Model of Aggressive Autoimmune Inflammation.
    Diabetes. 2026 Jul 31:db251007. doi: 10.2337/db25-1007.
    

    >> Share

    
    
12. CHEN F, Zhang Y, Wang W, Li G, et al
    Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes.
    Diabetes. 2026;75:1934-1945.
    

    >> Share

    
    
13. AMENDOLARA R, De Vita F, Buzzetti R, Maddaloni E, et al
    Response to Comment on Amendolara et al. Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
    Diabetes. 2026;75:e39.
    

    >> Share

    
    
14. RAINERI D, Chiocchetti A
    Response to Comments on Raineri et al. Memory Regulatory T Cells as a Biomarker of Early Type 1 Diabetes.
    Diabetes. 2026;75:e31-e33.
    

    >> Share

    
    
15. CHEN J, Zhao Q, Hua Y, Zhao Y, et al
    Comment on Meier et al. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.
    Diabetes. 2026;75:e34-e35.
    

    >> Share

    
    
16. PETSIOU A, Vartholomatos G, Paschou SA, Chatzigianni K, et al
    Comment on Raineri et al. Memory Regulatory T Cells as a Biomarker of Early Type 1 Diabetes.
    Diabetes. 2026;75:e27-e28.
    

    >> Share

    
    
17. PAGE B
    Diabetes Spotlight: Mark A. Herman, MD-The Metabolic Effects of Excess Nutrients.
    Diabetes. 2026;75:1711-1712.
    

    >> Share

    
    
18. MEIER CZ, Birkenfeld AL, Fritsche A, Stefan N, et al
    Response to Comment on Meier et al. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.
    Diabetes. 2026;75:e36.
    

    >> Share

    
    
19. CHEN J, Feng Z, Chen S
    Comment on Lyu et al. Type 2 Diabetes Reduces IFN-alpha2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice.
    Diabetes. 2026;75:e40-e41.
    

    >> Share

    
    
20. CHEN J, Lin Y, Yang Y
    Comment on Amendolara et al. Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
    Diabetes. 2026;75:e37-e38.
    

    >> Share

    
    
21. BRUZZANITI S, Piemonte E, Galgani M
    Comment on Raineri et al. Memory Regulatory T Cells as a Biomarker of Early Type 1 Diabetes.
    Diabetes. 2026;75:e29-e30.
    

    >> Share

    
    
22. GOOTJES C, Nikolic T, Roep BO
    Comment on Raineri et al. Memory Regulatory T Cells as a Biomarker of Early Type 1 Diabetes.
    Diabetes. 2026;75:e25-e26.
    

    >> Share

    
    

    
    Diabetes Care

23. SATTAR N, Gerstein HC, D'Alessio D, Bhatt DL, et al
    Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.
    Diabetes Care. 2026;49:1771-1778.
    

    >> Share

    
    
24. FLEMING GA, Mathieu C, Skyler JS
    The Importance of C-Peptide for Developing T1D Disease-Modifying Therapies.
    Diabetes Care. 2026;49:1752-1756.
    

    >> Share

    
    
25. RAWSHANI A, Eliasson B, McGuire DK, Sattar N, et al
    Association of Age at Type 1 Diabetes Onset With Survival, Cardiovascular, and Kidney Outcomes: A Nationwide Cohort Study.
    Diabetes Care. 2026 Sep 21:dc260200. doi: 10.2337/dc26-0200.
    

    >> Share

    
    
26. CHEN L, Wang J
    Semaglutide Effects on Insulin Sensitivity and beta-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial W
    Diabetes Care. 2026 Sep 21:dc260540. doi: 10.2337/dc26-0540.
    

    >> Share

    
    
27. TOKI R, Sakamoto M, Takebayashi T
    Response to Comments on Toki et al. Seasonal BMI Amplitude and Risk of Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).
    Diabetes Care. 2026;49:e176-e177.
    

    >> Share

    
    
28. LIU T, Zhu X, Wu Z
    Comment on Toki et al. Seasonal BMI Amplitude and Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).
    Diabetes Care. 2026;49:e174-e175.
    

    >> Share

    
    
29. SHANG Y, Jin J, He Q
    Comment on Toki et al. Seasonal BMI Amplitude and Risk of Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).
    Diabetes Care. 2026;49:e173.
    

    >> Share

    
    
30. 
    Automated Insulin Delivery for Pregnancy With Type 1 Diabetes: A Call to Action.
    Diabetes Care. 2026 Sep 24:dci260045. doi: 10.2337/dci26-0045.
    

    >> Share

    
    

    
    Diabetes Obes Metab

31. TAO Y, Yu H, Ma Y, Yuan M, et al
    Multimodal Exploratory Analysis of Persistent Diabetic Macular Edema: Integrating Aqueous Humour Metabolomics, Clinical and OCT Features.
    Diabetes Obes Metab. 2026 Sep 20. doi: 10.1111/dom.71173.
    

    >> Share

    
    
32. CALDERON E, Bjerg L, Isaksen AA, Sandbaek A, et al
    Sex and Socioeconomic Differences in the Initiation of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort Study.
    Diabetes Obes Metab. 2026 Sep 20. doi: 10.1111/dom.71334.
    

    >> Share

    
    
33. BALDASSARRE MPA, Di Dalmazi G, Carrieri F, Centorame G, et al
    Oral Semaglutide in Routine Clinical Practice: 24-Month Real-World Effectiveness, Persistence and Safety in Adults With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Sep 21. doi: 10.1111/dom.71371.
    

    >> Share

    
    
34. 
    Correction to 'Analysis of Patient Characteristics and Safety of Insulin Glargine U300 Use in 21 359 Patients With Type-2 Diabetes and Chronic Kidney Disease: DPV Registry Study'.
    Diabetes Obes Metab. 2026 Sep 23. doi: 10.1111/dom.71370.
    

    >> Share

    
    
35. GRIFFITHS B, Mehar S, Blangiardo M, Bottle A, et al
    Evaluating the Effectiveness of the Reducing Weight With Intensive Dietary Support (REWIND) Programme on Type 2 Diabetes Remission.
    Diabetes Obes Metab. 2026 Sep 23. doi: 10.1111/dom.71364.
    

    >> Share

    
    

    
    Diabetologia

36. CARLSSON S, Tuomi T, Lampousi AM
    Lifestyle and environmental risk factors for adult-onset autoimmune diabetes: current evidence and future directions.
    Diabetologia. 2026 Sep 25. doi: 10.1007/s00125-026-06878.
    

    >> Share

    
    
37. FU Q, Wang K, Shen M, Shen S, et al
    Shared non-HLA genetic architecture across diverse ancestries links insulin secretion and resistance to type 1 diabetes.
    Diabetologia. 2026 Sep 22. doi: 10.1007/s00125-026-06865.
    

    >> Share

    
    
38. EHRMANN D, Hermanns N, Schmitt A, Klinker LY, et al
    Temporal dynamics of daily diabetes-specific burdens using intensive longitudinal data: the central role of feelings of guilt within a multilevel network analysis.
    Diabetologia. 2026 Sep 21. doi: 10.1007/s00125-026-06869.
    

    >> Share

    
    

    
    Eur J Endocrinol

39. HENNEY AE, Davison AS, Alam U, Cuthbertson DJ, et al
    Increased risk of steatotic liver disease, major adverse liver outcomes, cardiovascular events, and mortality in pheochromocytoma: a model of chronically elevated sympathetic tone.
    Eur J Endocrinol. 2026;195:529-539.
    

    >> Share

    
    

    
    Invest Ophthalmol Vis Sci

40. MIDENA E, Lupidi M, Frizziero L, Midena G, et al
    The Behavior of the External Limiting Membrane and Ellipsoid Zone in Diabetic Macular Edema: A Population AI-Assisted Optical Coherence Tomography Study.
    Invest Ophthalmol Vis Sci. 2026;67:40.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

41. TAKAHARA M, Soga Y, Iida O
    Diabetes duration and advanced diabetes-related complications in lower-extremity versus coronary revascularization.
    J Clin Endocrinol Metab. 2026 Sep 25:dgag387. doi: 10.1210.
    

    >> Share

    
    
42. SABAG A, Biswas RK, Koemel NA, Francois ME, et al
    The dose-response association between wearables-quantified incidental physical activity and type 2 diabetes: a prospective cohort study.
    J Clin Endocrinol Metab. 2026 Sep 24:dgag316. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

43. TANG W, Luo R, Luo Y, Yu S, et al
    Prediction models for sarcopenia risk in type 2 diabetes mellitus: A systematic review and meta-analysis.
    J Diabetes Complications. 2026;40:109416.
    

    >> Share

    
    
44. BLOMSTRAND H, Halling A, Agvall B
    Three-year incidence and predictors of mortality and microvascular and macrovascular complications after newly diagnosed type 2 diabetes: A population-based cohort study.
    J Diabetes Complications. 2026;40:109415.
    

    >> Share

    
    
45. NEHME M, Baseme IS, Messier V, Dawe P, et al
    Diabetes phenotyping, insulin management and complications in latent autoimmune diabetes in adults (LADA): patient-reported outcomes of the Canadian BETTER registry.
    J Diabetes Complications. 2026;40:109417.
    

    >> Share

    
    
46. PATOULIAS D, Muzurovic E, Rizzo M, Mantzoros CS, et al
    Switching from glucagon-like peptide-1 receptor agonists to tirzepatide in type 2 diabetes: does therapeutic sequencing matter for metabolic dysfunction-associated steatotic liver disease?
    J Diabetes Complications. 2026 Sep 18:109418.
    

    >> Share

    
    

    
    J Hypertens

47. ANNESI L, Agnoletti D, Angilletta E, Baracchi A, et al
    Maternal macrovascular and microvascular adaptation in healthy pregnancy, gestational diabetes, and hypertensive disorders of pregnancy.
    J Hypertens. 2026 Sep 18. doi: 10.1097/HJH.0000000000004414.
    

    >> Share

    
    

    
    Obstet Gynecol

48. WERNER EF
    Milestones in Motion: Gestational Diabetes.
    Obstet Gynecol. 2026 Sep 22. doi: 10.1097/AOG.0000000000006433.
    

    >> Share

    
    

    
    Pediatrics

49. MONZON AD, Hoover JC, Pierce JS, Wasserman R, et al
    Behavioral Interventions in Pediatric Type 1 Diabetes Management: An Updated Meta-Analysis.
    Pediatrics. 2026 Sep 24:e2025075333. doi: 10.1542/peds.2025-075333.
    

    >> Share

    
    

    
    PLoS Med

50. BERGMAN E, Nordstrom A, Nyberg L, Nordstrom P, et al
    Association of a multiple risk factor assessment and intervention program with risk of diabetes: A population-based matched cohort study.
    PLoS Med. 2026;23:e1005043.
    

    >> Share

    
    

    
    PLoS One

51. FENG R, Wang X, Li X, Zhao Z, et al
    Identification and mechanistic investigation of novel biomarkers for diabetic retinopathy through hypoxia- and cuproptosis-associated gene analysis.
    PLoS One. 2026;21:e0358182.
    

    >> Share

    
    
52. CUADRADO-CORRALES N, Merida DM, Lopez-de-Andres A, Zamorano-Leon JJ, et al
    Nationwide trends in dementia subtypes and in-hospital mortality among hospitalizations with type 2 diabetes in Spain, 2021-2024: A focus on sex disparities.
    PLoS One. 2026;21:e0358874.
    

    >> Share

    
    
53. KAZI MAI, Mufarrih SM, Sirohi A, Hasan F, et al
    Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study.
    PLoS One. 2026;21:e0358659.
    

    >> Share

    
    
54. GU Z, Xi T, Luo X
    Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits.
    PLoS One. 2026;21:e0358993.
    

    >> Share

    
    
55. YAN J, Song Y, Du Y, Li F, et al
    Performance of machine learning-based prediction models for hypoglycemia in Chinese patients with diabetes: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0358876.
    

    >> Share

    
    
56. CHEN X, Lei M, Tang J, Wang H, et al
    Efficacy, safety, and feasibility of youth-derived fecal microbiota transplantation among adults with type 1 diabetes mellitus: A protocol of Pilot Randomized Controlled Trial.
    PLoS One. 2026;21:e0343078.
    

    >> Share

    
    

    
    Retina

57. HUANG RS, Naidu SC, Mihalache A, Benour A, et al
    Loss to Follow-Up and Subway Proximity in Proliferative Diabetic Retinopathy and Diabetic Macular Edema: CLEAR Study Report 2.
    Retina. 2026 Sep 21. doi: 10.1097/IAE.0000000000005018.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share